- Home
- AUB vs ZLAB Comparison
AUB vs ZLAB Comparison
Compare AUB & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUB
- ZLAB
- Stock Information
- Founded
- AUB 1902
- ZLAB 2013
- Country
- AUB United States
- ZLAB China
- Employees
- AUB N/A
- ZLAB N/A
- Industry
- AUB Major Banks
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- AUB Finance
- ZLAB Health Care
- Exchange
- AUB Nasdaq
- ZLAB Nasdaq
- Market Cap
- AUB 3.5B
- ZLAB 3.6B
- IPO Year
- AUB N/A
- ZLAB 2017
- Fundamental
- Price
- AUB $29.90
- ZLAB $34.55
- Analyst Decision
- AUB Buy
- ZLAB Buy
- Analyst Count
- AUB 6
- ZLAB 4
- Target Price
- AUB $39.17
- ZLAB $47.37
- AVG Volume (30 Days)
- AUB 1.4M
- ZLAB 1.0M
- Earning Date
- AUB 07-24-2025
- ZLAB 08-05-2025
- Dividend Yield
- AUB 4.52%
- ZLAB N/A
- EPS Growth
- AUB N/A
- ZLAB N/A
- EPS
- AUB 2.15
- ZLAB N/A
- Revenue
- AUB $797,879,000.00
- ZLAB $418,326,000.00
- Revenue This Year
- AUB $76.85
- ZLAB $44.07
- Revenue Next Year
- AUB $15.84
- ZLAB $49.13
- P/E Ratio
- AUB $13.96
- ZLAB N/A
- Revenue Growth
- AUB 16.62
- ZLAB 43.72
- 52 Week Low
- AUB $22.85
- ZLAB $16.01
- 52 Week High
- AUB $44.54
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- AUB 47.45
- ZLAB 49.05
- Support Level
- AUB $29.44
- ZLAB $36.36
- Resistance Level
- AUB $32.73
- ZLAB $44.34
- Average True Range (ATR)
- AUB 0.72
- ZLAB 1.45
- MACD
- AUB -0.16
- ZLAB -0.16
- Stochastic Oscillator
- AUB 16.27
- ZLAB 39.20
About AUB Atlantic Union Bankshares Corporation
Atlantic Union Bankshares Corp is a financial holding company and a bank holding company. Through its community bank subsidiary, the company provides financial services, including banking, trust, and wealth management. The bank is a full-service community bank offering consumers and businesses a wide range of banking and related financial services, including checking, savings, certificates of deposit, and other depository services, as well as loans for commercial, industrial, residential mortgage, and consumer purposes. The company operates through two reportable operating segments: Wholesale Banking and Consumer Banking, with corporate support functions such as corporate treasury and others included in Corporate Other. It derives maximum revenue from Wholesale Banking.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.